FOXC1 and cancer: Studies have found that the upregulation of FOXC1 is related to the poor prognosis of a variety of human cancers, including acute myeloid leukemia [26], basal-like breast cancer [27], hepatocellular carcinoma [28], pancreatic duct adenocarcinoma [29], and gastric cancer [30].